Artifact suppression and improved signal-to-noise ratio by phase-locked multiplexed coherent imaging
Optics Letters · 01.02.2024 · 49 (3) · 738
DOI: 10.1364/ol.503939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Optics Letters, online erschienen am 31.01.2024. Verfasst von Michael Giamberardino und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Laser additive manufacturing (AM) promises direct metal 3D printing, but is held back by defects and process instabilities, giving rise to a need for in situ process monitoring. Inline coherent imaging (ICI) has proven effective for in situ , direct measurements of vapor depression depth and shape in AM and laser welding but struggles to track turbulent interfaces due to poor coupling back into a single-mode fiber and the presence of artifacts. By z-domain multiplexing, we achieve phase-sensitive image consolidation, automatically attenuating autocorrelation artifacts and improving interface tracking rates by 58% in signal-starved applications.
Förderung
- Canada Foundation for Innovation
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Giamberardino, M., Krause, T. J. H., & Fraser, J. M. (2024). Artifact suppression and improved signal-to-noise ratio by phase-locked multiplexed coherent imaging. Optics Letters, 49(3), 738. https://doi.org/10.1364/ol.503939
Vancouver
Giamberardino M, Krause TJH, Fraser JM. Artifact suppression and improved signal-to-noise ratio by phase-locked multiplexed coherent imaging. Optics Letters. 2024;49(3):738. doi:10.1364/ol.503939
BibTeX
@article{Giamberardino2024,
author = {Giamberardino, Michael and Krause, Tessa J H and Fraser, James M},
title = {Artifact suppression and improved signal-to-noise ratio by phase-locked multiplexed coherent imaging},
journal = {Optics Letters},
year = {2024},
volume = {49},
number = {3},
pages = {738},
doi = {10.1364/ol.503939}
}
EUVIMED